IPO registrations (S-1, F-1) · Registrants
VNUS MEDICAL TECHNOLOGIES INC
- SEC CIK
- 1040666 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2000-08-18, last 2004-10-19; 2 initial registrations, 8 amendments
- Outcome
- Final prospectus filed 2004-10-20; withdrawal requested 2001-04-20
- Industry (SIC)
- Electromedical & Electrotherapeutic Apparatus 3845
- Business address
- 5799 FONTANOSO WAY, San Jose, CA 95138-1015
- EIN
- 94-3216535
- EDGAR entity type
- operating
- Insiders and CEO pay
- VNUS MEDICAL TECHNOLOGIES INC on the corporate pages
Offering terms
- Proposed price range
- $13.00–$15.00 per share (S-1/A filed 2004-10-19)
- Final price
- $15.00 per share, within the range (424B4 filed 2004-10-20, an initial public offering)
- Shares sold
- 5,375,995 (4,000,000 by the company, 1,375,995 by selling holders)
- Gross proceeds
- $80,639,925 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol VNUS
- Lead underwriters
- BofA Securities; Piper Sandler (2,284,798 shares); William Blair (806,399 shares)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Form 5500 plan sponsor: VNUS MEDICAL TECHNOLOGIES EXACT (EIN (EXACT))
- Federal award recipient: VNUS MEDICAL TECHNOLOGIES, INC. Fuzzy (name and state)
- SEC filer: VNUS MEDICAL TECHNOLOGIES INC EXACT (CIK (EXACT))
Filings 13
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2000-08-18 | S-1 | S-1 (registration) | VNUS MEDICAL TECHNOLOGIES INC | 0001095811-00-002905 ↗ |
| 2000-09-27 | S-1/A | S-1/A (amendment) | VNUS MEDICAL TECHNOLOGIES INC | 0001095811-00-003609 ↗ |
| 2000-10-16 | S-1/A | S-1/A (amendment) | VNUS MEDICAL TECHNOLOGIES INC | 0000891618-00-004879 ↗ |
| 2000-10-23 | S-1/A | S-1/A (amendment) | VNUS MEDICAL TECHNOLOGIES INC | 0001095811-00-004011 ↗ |
| 2001-04-20 | RW | RW (withdrawal request) | VNUS MEDICAL TECHNOLOGIES INC | 0000891618-01-500348 ↗ |
| 2004-07-23 | S-1 | S-1 (registration) | VNUS MEDICAL TECHNOLOGIES INC | 0000891618-04-001139 ↗ |
| 2004-08-18 | S-1/A | S-1/A (amendment) | VNUS MEDICAL TECHNOLOGIES INC | 0000950134-04-012519 ↗ |
| 2004-09-07 | S-1/A | S-1/A (amendment) | VNUS MEDICAL TECHNOLOGIES INC | 0000891618-04-001222 ↗ |
| 2004-09-28 | S-1/A | S-1/A (amendment) | VNUS MEDICAL TECHNOLOGIES INC | 0000891618-04-001261 ↗ |
| 2004-10-15 | S-1/A | S-1/A (amendment) | VNUS MEDICAL TECHNOLOGIES INC | 0000891618-04-001285 ↗ |
| 2004-10-19 | S-1/A | S-1/A (amendment) | VNUS MEDICAL TECHNOLOGIES INC | 0000950134-04-015251 ↗ |
| 2004-10-20 | S-1MEF | S-1MEF (added securities) | VNUS MEDICAL TECHNOLOGIES INC | 0000950134-04-015293 ↗ |
| 2004-10-20 | 424B4 | 424B4 (final prospectus) | VNUS MEDICAL TECHNOLOGIES INC | 0000950134-04-015322 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2004-10-19 | S-1/A | registration statement | $13.00–$15.00 | 4,709,328 | - | Nasdaq VNUS | 3 | primary document; range, price line, shares headline, proceeds computed, price outside the range dropped | document ↗ | |
| 2004-10-20 | 424B4 | final prospectus | $15.00 | 5,375,995 | $80,639,925 | Nasdaq VNUS | 3 | primary document; price sentence, shares headline, proceeds table, underwriting table 2 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Cramer Scott H | Officer | Sr VP of US Sales; Sr. VP of U.S. Sales; Sr VP, US Sales & Account Svcs; Sr VP US Sales & Acct Svcs; Sr VP US Sales & Acct. Svcs.; Sr. VP, U.S. Sales & Acct Svcs; Sr. VP, US Sales & Acct. Svcs; Sr VP US Sales and Acct Svcs; Sr. VP US Sales and Acct. Svcs | 12 | 2006–2007 | |
| Cunningham Lian Xue | Officer | Med Dir & VP Clin Res & Ed; Med Dir & VP Clin.Res.& Ed.; Med Dir. & VP Clin. Res.& Ed.; Med. Dir. & VP, Clin Res & Ed; Med. Dir. & VP, Clin Res & Ed.; Med. Dir. & VP, Clin. Res & Ed | 14 | 2006–2008 | |
| Farley Brian E | Director,Officer | President and CEO; President & CEO | 37 | 2006–2009 | |
| Friedman Charlene | Officer | VP, Gen Counsel and Corp Sec; VP, Gen Counsel and Corp. Sec.; VP, Gen. Counsel and Corp Sec.; VP, Gen. Counsel & Corp. Sec.; VP General Counsel & Corp Sec | 9 | 2006–2007 | |
| Marcotte Timothy A | Officer | CFO, VP Finance and Admin. | 5 | 2006–2007 | |
| McRae Robert | Officer | VP Bus. Dev. & Manufacturing; VP BUS. DEV. & MANUFACTURING; VP of Business Development | 4 | 2006–2007 | |
| Rosenberg Dennis | Officer | VP Marketing & Intl. Sales; VP of Marketing and Intl Sales; VP of Marketing & Intl. Sales | 6 | 2006–2007 | |
| Fitzsimmons W James | Director | 15 | 2006–2009 | ||
| SCHIFFMAN GREGORY T | Director | 14 | 2006–2009 | ||
| SANCHETI MOHAN | Officer | Sr. VP of Manufacturing; SVP of Manufacturing; VP of Manufacturing | 21 | 2006–2009 | |
| COYLE MICHAEL J | Director | 13 | 2006–2009 | ||
| LAPORTE KATHLEEN | Director | 7 | 2006–2008 | ||
| ROBSON LORI | Director | 15 | 2006–2009 | ||
| Unkart Edward W | Director | 13 | 2006–2009 | ||
| Franklin William | Officer | VP, Reg Affairs and Qual Assur; VP, Reg. Affairs & Qual Assur; VP, Reg. Affairs & Qual. Assur; VP,Reg. Affairs & Qual. Assur.; VP, Regulatory Affairs & QA | 14 | 2007–2009 | |
| Saxton Mark | Officer | VP, U.S. Sales | 22 | 2007–2009 | |
| CREDIT SUISSE/ | TenPercentOwner | 3 | 2007–2008 | ||
| Kamdar Kirti | Officer | SVP of Research & Development; SVP, Research and Development | 10 | 2007–2009 | |
| Osborne Peter | Officer | CFO, VP of Finance and Admin. | 7 | 2008–2009 | |
| Murcray Scott | Officer | Principal Accounting Officer | 6 | 2008–2009 | |
| Todd Donald J | Officer | Vice President of Marketing | 5 | 2008–2009 | |
| Smeets Guido E | Officer | VP, Clinical Research and CMO | 3 | 2008–2009 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Federal award recipient | VNUS MEDICAL TECHNOLOGIES, INC. | CA | Federal spending (USAspending) | name and state |
| SEC filer | VNUS MEDICAL TECHNOLOGIES INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | VNUS Medical Technologies, Inc. | CA | Trademarks (USPTO) | name and state |
| Form 5500 plan sponsor | VNUS MEDICAL TECHNOLOGIES | EIN (EXACT) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Electromedical & Electrotherapeutic Apparatus, CA first:
- ENDOCARE INC CA
- IMAGYN MEDICAL INC CA
- CARDIAC PATHWAYS CORP CA
- ARADIGM CORP CA
- ORATEC INTERVENTIONS INC CA
- RITA MEDICAL SYSTEMS INC CA
- CURON MEDICAL INC CA
- CUTERA INC CA
- INTRALASE CORP CA
- SOLTA MEDICAL INC CA
In other datasets, the same topic (Technology) in CA:
- Lobbying client: 8X8, INC. (Federal lobbying (LDA))
Interests: Electromedical & Electrotherapeutic Apparatus · Technology